Status:
UNKNOWN
Telemedicine for First Trimester Abortion in South Africa
Lead Sponsor:
University of Cape Town
Collaborating Sponsors:
Grand Challenges Canada
University of California, San Francisco
Conditions:
Abortion in First Trimester
Eligibility:
FEMALE
18-44 years
Phase:
NA
Brief Summary
The study aim to determine if medical abortion facilitated by a physician online (s.c. telemedicine), combined with a simplified physical exam, is equally effective, safe and acceptable to women in So...
Detailed Description
The proposed study is non-inferiority randomized controlled trial that will investigate the safety, effectiveness and acceptability for women of early medical abortion performed through telemedicine, ...
Eligibility Criteria
Inclusion
- Able to read and write
- Able to speak English, IsiXhosa or Afrikaans
- Gestational age \<9 wks 2 days
- In possession of a smartphone
Exclusion
- Contraindication to medical abortion
Key Trial Info
Start Date :
February 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 15 2021
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT04336358
Start Date
February 27 2020
End Date
November 15 2021
Last Update
April 30 2021
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Karl Bremer Hospital
Bellville, Western Cape, South Africa, 7530
2
Vanguard CHC
Cape Town, Western Cape, South Africa, 7764
3
Michael Mapongwana CHC
Khayelitsha, Western Cape, South Africa, 7784
4
Mitchells Plain CHC
Mitchells Plain, Western Cape, South Africa, 7785